Showing 671-680 of 23030 results for "".
Washington's Push For Evidence-Based Medicine
https://reachmd.com/programs/clinicians-roundtable/washingtons-push-for-evidence-based-medicine/4373/Evidence-based medicine has been gaining momentum among the medical community, but there are things happening in our nation's capital that could impact this coming trend. Dr. Les Paul, vice president of clinical and scientific affairs for the National Pharmaceutical Council, tells host Bruce JapsenComparative Effectiveness and the Economic Stimulus Package
https://reachmd.com/programs/clinicians-roundtable/comparative-effectiveness-and-the-economic-stimulus-package/4372/Comparative effectiveness is gaining momentum as a way to decide what drugs and devices should be used by doctors. But why was it part of the economic stimulus approved by Congress and pushed by President Obama? Dr. Les Paul, vice president of clinical and scientific affairs at the National PharmaceA Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
https://reachmd.com/programs/cme/a-novel-therapeutic-approach-in-myeloid-malignancies-targeting-the-neddylation-pathway/11694/Learn about emerging NEDD8-activating enzyme inhibitors in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).A Deep Dive into the Management of AEs Associated with ADCs
https://reachmd.com/programs/cme/a-deep-dive-into-the-management-of-aes-associated-with-adcs/13767/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!Forgetfulness Interventions
https://reachmd.com/programs/clinicians-roundtable/forgetfulness-interventions/3224/Do you believe that if a patient is worried that they are developing Alzheimer's that it can't be dementia? What do you do when a high functioning patient complains of being unable to remember names? Say, "Me too!"? Perhaps we all have a thing or two to learn about working up forgetfulness. Host DrRefining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
https://reachmd.com/programs/project-oncology/refining-first-line-therapy-in-advanced-endometrial-care-leap-001-trial-results/35507/To explore a potential alternative to chemotherapy, the ENGOT-en9/LEAP-001 trial compared lenvatinib/pembrolizumab to standard chemotherapy in patients with advanced or recurrent endometrial cancer. Learn how these results may shape biomarker-driven approaches and patient selection in frontline endoOptimizing Public Health Messaging: Lessons from the COVID-19 Response
https://reachmd.com/programs/clinicians-roundtable/optimizing-public-health-messaging-lessons-from-the-covid-19-response/35467/Clear and consistent communication is a cornerstone of public health, but during the COVID-19 pandemic, the preference for simple messaging often conflicted with the scientific uncertainty surrounding a novel virus. Hear Dr. Amesh Adaljia discuss why acknowledging scientific limitations, communicatiAddressing Maternal Morbidity and Mortality in the US: Who Will Take the Lead?
https://reachmd.com/programs/clinicians-roundtable/addressing-maternal-morbidity-and-mortality-in-the-us-who-will-take-the-lead/6980/Despite numerous advances in maternal-fetal medicine over the past decades, maternal morbidity and mortality continues to plague labor and delivery wards across the U.S. What are the various clinical, social, and economic determinants of health for expectant mothers, and what partnerships exist to iAssessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
https://reachmd.com/programs/project-oncology/assessing-atirmociclib-plus-letrozole-in-hrher2-metastatic-breast-cancer/36160/A study presented at the 2025 ESMO Congress evaluated the safety and efficacy of first-line atirmociclib combined with letrozole for patients with HR+/HER2- metastatic breast cancer. This Phase 1 trial focused on treatment-naive patients and explored whether selective CDK4 inhibition with continuousNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia
https://reachmd.com/programs/lipid-luminations/national-lipid-association-recommendations-for-patient-centered-management-of-dyslipidemia/6963/Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past